MCAT elements and the TEF-1 family of transcription factors in muscle development and disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 1, 2008, Pages 8-17

  Yoshida, Tadashi ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cardiac muscle; MCAT element; Myofibroblasts; Skeletal muscle; Smooth muscle; Transcriptional enhancer factor 1

Indexed keywords

ALPHA 1C ADRENERGIC RECEPTOR; ALPHA ACTIN; ALPHA SMOOTH MUSCLE ACTIN; ALPHA TROPOMYOSIN; CHOLINERGIC RECEPTOR; MYOCARDIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TEF 1; TROPONIN T; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ASPERGILLUS NIDULANS; CARDIOVASCULAR DISEASE; CHICKEN; DNA FLANKING REGION; FLY; GENETIC TRANSCRIPTION; HEART MUSCLE; HUMAN; KNOCKOUT MOUSE; MOUSE STRAIN; MUSCLE DEVELOPMENT; MUSCLE DISEASE; MUTATIONAL ANALYSIS; NONHUMAN; PHOSPHORYLATION; PLANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT STRAIN; SACCHAROMYCES CEREVISIAE; SHORT SURVEY; SKELETAL MUSCLE; SMOOTH MUSCLE; TRANSCRIPTION REGULATION;

ANIMALS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART DISEASES; HUMANS; INTERSPERSED REPETITIVE SEQUENCES; MICE; MUSCLE CELLS; MYOGENIC REGULATORY FACTORS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 37549049708     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.155788     Document Type: Short Survey

References (85)

1. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767-801.
2. Olson EN. Gene regulatory networks in the evolution and development of the heart. Science. 2006;313:1922-1927.
3. Tapscott SJ. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development. 2005;132:2685-2695.
4. Yoshida T, Owens GK. Molecular determinants of vascular smooth muscle cell diversity. Circ Res. 2005;96:280-291.
5. Cooper TA, Ordahl CP. A single cardiac troponin T gene generates embryonic and adult isoforms via developmentally regulated alternate splicing. J Biol Chem. 1985;260:11140-11148.
6. Mar JH, Ordahl CP. A conserved CATTCCT motif is required for skeletal muscle-specific activity of the cardiac troponin T gene promoter. Proc Natl Acad Sci U S A. 1988;85:6404-6408.
7. Rindt H, Gulick J, Knotts S, Neumann J, Robbins J. In vivo analysis of the murine β-myosin heavy chain gene promoter. J Biol Chem. 1993;268: 5332-5338.
8. Swartz EA, Johnson AD, Owens GK. Two MCAT elements of the SM α-actin promoter function differentially in SM vs. non-SM cells. Am J Physiol. 1998;275:C608-C618.
9. 1-adrenergic induction of the skeletal α-actin promoter during cardiac myocyte hypertrophy: transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth. J Biol Chem. 1995;270:410-417.
10. Davidson I, Xiao JH, Rosales R, Staub A, Chambon P. The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequence. Cell. 1988;54:931-942.
11. Xiao JH, Davidson I, Matthes H, Garnier JM, Chambon P. Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell. 1991;65:551-568.
12. Ishiji T, Lace MJ, Parkkinen S, Anderson RD, Haugen TH, Cripe TP, Xiao J-H, Davidson I, Chambon P, Turek LP. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. EMBO J. 1992;11:2271-2281.
13. Jiang S-W, Wu K, Eberhardt NL. Human placental TEF-5 transactivates the human chorionic somatomammotropin gene enhancer. Mol Endocrinol. 1999;13:879-889.
14. Sawada A, Nishizaki Y, Sato H, Yada Y, Nakayama R, Yamamoto S, Nishioka N, Kondoh H, Sasaki H. Tead proteins activate the Foxa2 enhancer in the node in cooperation with a second factor. Development. 2005;132:4719-4729.
15. Jiang S-W, Desai D, Khan S, Eberhardt NL. Cooperative binding of TEF-1 to repeated GGAATG-related consensus elements with restricted spatial separation and orientation. DNA Cell Biol. 2000;19:507-514.
16. Mar JH, Ordahl CP. M-CAT binding factor, a novel trans-acting factor governing muscle-specific transcription. Mol Cell Biol. 1990;10: 4271-4283.
17. Farrance IKG, Mar JH, Ordahl CP. M-CAT binding factor is related to the SV40 enhancer binding factor, TEF-1. J Biol Chem. 1992;267: 17234-17240.
18. Stewart AFR, Richard CW III, Suzow J, Stephan D, Weremowicz S, Morton CC, Adra CN. Cloning of human RTEF-1, a transcriptional enhancer factor-1-related gene preferentially expressed in skeletal muscle: evidence for an ancient multigene family. Genomics. 1996;36: 68-76.
19. Yockey CE, Smith G, Izumo S, Shimizu N. cDNA cloning and characterization of murine transcriptional enhancer factor-1-related protein 1, a transcription factor that binds to the M-CAT motif. J Biol Chem. 1996; 271:3727-3736.
20. Yasunami M, Suzuki K, Ohkubo H. A novel family of TEA domain-containing transcription factors with distinct spatiotemporal expression patterns. Biochem Biophys Res Commun. 1996;228:365-370.
21. Jacquemin P, Hwang J-J, Martial JA, Dollé P, Davidson I. A novel family of developmentally regulated mammalian transcription factors containing the TEA/ATTS DNA binding domain. J Biol Chem. 1996;271:21775-21785.
22. Hsu DKW, Guo Y, Alberts GF, Copeland NG, Gilbert DJ, Jenkins NA, Peifley KA, Winkles JA. Identification of a murine TEF-1-related gene expressed after mitogenic stimulation of quiescent fibroblasts and during myogenic differentiation. J Biol Chem. 1996;271:13786-13795.
23. Yasunami M, Suzuki K, Houtani T, Sugimoto T, Ohkubo H. Molecular characterization of cDNA encoding a novel protein related to transcriptional enhancer factor-1 from neural precursor cells. J Biol Chem. 1995; 270:18649-18654.
24. Azakie A, Larkin SB, Farrance IK, Grenningloh G, Ordahl CP. DTEF-1, a novel member of the transcription enhancer factor-1 (TEF-1) multigene family. J Biol Chem. 1996;271:8260-8265.
25. 1-adrenergic reactivation of the fetal gene program in cardiac myocytes. Circ Res. 1998;83:43-49.
26. Bürglin TR. The TEA domain: a novel, highly conserved DNA binding motif. Cell. 1991;66:11-12.
27. Campbell S, Inamdar M, Rodrigues V, Raghavan V, Palazzolo M, Chovnick A. The scalloped gene encodes a novel, evolutionarily conserved transcription factor required for sensory organ differentiation in Drosophila. Genes Dev. 1992;6:367-379.
28. Carlini LE, Getz MJ, Strauch AR, Kelm RJ Jr. Cryptic MCAT enhancer regulation in fibroblasts and smooth muscle cells: suppression of TEF-1 mediated activation by the single-stranded DNA-binding proteins, Purα, Purβ, and MSY1. J Biol Chem. 2002;277:8682-8692.
29. Azakie A, LaMont L, Fineman JR, He Y. Divergent transcriptional enhancer factor-1 regulates the cardiac troponin T promoter. Am J Physiol Cell Physiol. 2005;289:C1522-C1534.
30. Kaneko KJ, Cullinan EB, Latham KE, DePamphilis ML. Transcription factor mTEAD-2 is selectively expressed at the beginning of zygotic gene expression in the mouse. Development. 1997;124:1963-1973.
31. Chen Z, Friedrich GA, Soriano P. Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice. Genes Dev. 1994;8:2293-2301.
32. Simpson PC, Kariya K, Karns LR, Long CS, Karliner JS. Adrenergic hormones and control of cardiac myocyte growth. Mol Cell Biochem. 1991;104:35-43.
33. 1-adrenergic agonist and activated β-protein kinase C in hypertrophy of cardiac myocytes. J Biol Chem. 1994;269:3775-3782.
34. Hasegawa K, Lee SJ, Jobe SM, Markham BE, Kitsis RN. cis-Acting sequences that mediate induction of β-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. Circulation. 1997;96:3943-3953.
35. Wright CE, Bodell PW, Haddad F, Qin AX, Baldwin KM. In vivo regulation of the β-myosin heavy chain gene in hypertensive rodent heart. Am J Physiol Cell Physiol. 2001;280:C1262-C1276.
36. Chen H-H, Baty CJ, Maeda T, Brooks S, Baker LC, Ueyama T, Gursoy E, Saba S, Salama G, London B, Stewart AFR. Transcription enhancer factor-1-related factor-transgenic mice develop cardiac conduction defects associated with altered connexin phosphorylation. Circulation. 2004;110:2980-2987.
37. Creemers EE, Sutherland LB, McAnally J, Richardson JA, Olson EN. Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development. Development. 2006;133: 4245-4256.
38. Gan Q, Yoshida T, Li J, Owens GK. Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle α-actin expression. Circ Res. 2007;101:883-892.
39. Pipes GCT, Creemers EE, Olson EN. The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev. 2006;20:1545-1556.
40. Du KL, Ip HS, Li J, Chen M, Dandre F, Yu W, Lu MM, Owens GK, Parmacek MS. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol. 2003;23:2425-2437.
41. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts: I. paracrine cells important in health and disease. Am J Physiol. 1999;277:C1-C19.
42. Manabe I, Owens GK. CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo. J Clin Invest. 2001;107:823-834.
43. Li L, Miano JM, Mercer B, Olson EN. Expression of the SM22α promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol. 1996;132:849-859.
44. Moessler H, Mericskay M, Li Z, Nagl S, Paulin D, Small JV. The SM22 promoter directs tissue-specific expression in arterial but not venous or visceral smooth muscle cells in transgenic mice. Development. 1996;122: 2415-2425.
45. Kim S, Ip HS, Lu MM, Clendenin C, Parmacek MS. A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages. Mol Cell Biol. 1997;17:2266-2278.
46. Carson JA, Yan Z, Booth FW, Coleman ME, Schwartz RJ, Stump CS. Regulation of skeletal α-actin promoter in young chickens during hypertrophy caused by stretch overload. Am J Physiol. 1995;268:C918-C924.
47. Carson JA, Schwartz RJ, Booth FW. SRF and TEF-1 control of chicken skeletal α-actin gene during slow-muscle hypertrophy. Am J Physiol. 1996;270:C1624-C1633.
48. Giger JM, Haddad F, Qin AX, Baldwin KM. Functional overload increases β-MHC promoter activity in rodent fast muscle via the proximal MCAT (βe3) site. Am J Physiol Cell Physiol. 2002;282:C518-C527.
49. Huey KA, Haddad F, Qin AX, Baldwin KM. Transcriptional regulation of the type I myosin heavy chain gene in denervated rat soleus. Am J Physiol Cell Phyiol. 2003;284:C738-C748.
50. Tsika GL, Wiedenman JL, Gao L, McCarthy JJ, Sheriff-Carter K, Rivera-Rivera ID, Tsika RW. Induction of β-MHC transgene in overloaded skeletal muscle is not eliminated by mutation of conserved elements. Am J Physiol. 1996;271:C690-C699.
51. Vyas DR, McCarthy JJ, Tsika RW. Nuclear protein binding at the β-myosin heavy chain A/T-rich element is enriched following increased skeletal muscle activity. J Biol Chem. 1999;274:30832-30842.
52. Karasseva N, Tsika G, Ji J, Zhang A, Mao X, Tsika R. Transcription enhancer factor 1 binds multiple muscle MEF2 and A/T-rich elements during fast-to-slow skeletal muscle fiber type transitions. Mol Cell Biol. 2003;23:5143-5164.
53. Zhao P, Caretti G, Mitchell S, McKeehan WL, Boskey AL, Pachman LM, Sartorelli V, Hoffman EP. Fgfr4 is required for effective muscle regeneration in vivo: delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway. J Biol Chem. 2006;281:429-438.
54. Milewski RC, Chi NC, Li J, Brown C, Lu MM, Epstein JA. Identification of minimal enhancer elements sufficient for Pax3 expression in neural crest and implication of Tead2 as a regulator of Pax3. Development. 2004;131:829-837.
55. Kaneko KJ, Kohn MJ, Liu C, DePamphilis ML. Transcription factor TEAD2 is involved in neural tube closure. Genesis. 2007;45:577-587.
56. 1-adrenergic signaling in hypertrophied cardiac myocytes. J Biol Chem. 2000;275:17476-17480.
57. 1-adrenergic agonist-stimulated cardiac myocytes. J Biol Chem. 2002;277:24346-24352.
58. Gupta MP, Kogut P, Gupta M. Protein kinase-A dependent phosphorylation of transcription enhancer factor-1 represses its DNA-binding activity but enhances its gene activation ability. Nucleic Acids Res. 2000;28:3168-3177.
59. Belandia B, Parker MG. Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors. J Biol Chem. 2000;275:30801-30805.
60. Vassilev A, Kaneko KJ, Shu H, Zhao Y, DePamphilis ML. TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev. 2001;15:1229-1241.
61. Mahoney WM Jr., Hong J-H, Yaffe MB, Farrance IKG. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem J. 2005;388:217-225.
62. Maeda T, Chapman DL, Stewart AFR. Mammalian Vestigial-like 2, a cofactor of TEF-1 and MEF2 transcription factors that promotes skeletal muscle differentiation. J Biol Chem. 2002;277:48889-48898.
63. 1- adrenergic activation of gene expression in cardiac myocytes. J Biol Chem. 2004;279:30800-30806.
64. Paumard-Rigal S, Zider A, Vaudin P, Silber J. Specific interactions between vestigial and scalloped are required to promote wing tissue proliferation in Drosophila melanogaster. Dev Genes Evol. 1998;208: 440-446.
65. Chen H-H, Maeda T, Mullett SJ, Stewart AFR. Transcription cofactor Vgl-2 is required for skeletal muscle differentiation. Genesis. 2004;39: 273-279.
66. Günther S, Mielcarek M, Krüger M, Braun T. VITO-1 is an essential cofactor of TEF1-dependent muscle-specific gene regulation. Nucleic Acids Res. 2004;32:791-802.
67. Gupta M, Kogut P, Davis FJ, Belaguli NS, Schwartz RJ, Gupta MP. Physical interaction between the MADS box of serum response factor and the TEA/ATTS DNA-binding domain of transcription enhancer factor-1. J Biol Chem. 2001;276:10413-10422.
68. Gupta MP, Amin CS, Gupta M, Hay N, Zak R. Transcription enhancer factor 1 interacts with a basic Helix-Loop-Helix zipper protein, Max, for positive regulation of cardiac α-myosin heavy-chain gene expression. Mol Cell Biol. 1997;17:3924-3936.
69. Maeda T, Gupta MP, Stewart AFR. TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters. Biochem Biophys Res Commun. 2002;294:791-797.
70. Cogan JG, Sun S, Stoflet ES, Schmidt LJ, Getz MJ, Strauch AR. Plasticity of vascular smooth muscle α-actin gene transcription: characterization of multiple, single-, and double-strand specific DNA-binding proteins in myoblasts and fibroblasts. J Biol Chem. 1995;270: 11310-11321.
71. Sun S, Stoflet ES, Cogan JG, Strauch AR, Getz MJ. Negative regulation of the vascular smooth muscle α-actin gene in fibroblasts and myoblasts: disruption of enhancer function by sequence-specific single-stranded-DNA-binding proteins. Mol Cell Biol. 1995;15:2429-2436.
72. Kelm RJ Jr., Elder PK, Strauch AR, Getz MJ. Sequence of cDNAs encoding components of vascular actin single-stranded DNA-binding factor 2 establish identity to Purα and Purβ. J Biol Chem. 1997;272: 26727-26733.
73. Kelm RJ Jr., Cogan JG, Elder PK, Strauch AR, Getz MJ. Molecular interactions between single-stranded DNA-binding proteins associated with an essential MCAT element in the mouse smooth muscle α-actin promoter. J Biol Chem. 1999;274:14238-14245.
74. Knapp AM, Ramsey JE, Wang S-X, Godburn KE, Strauch AR, Kelm RJ Jr. Nucleoprotein interactions governing cell type-dependent repression of the mouse smooth muscle α-actin promoter by single-stranded DNA-binding proteins Purα and Purβ. J Biol Chem. 2006;281:7907-7918.
75. Gupta M, Sueblinvong V, Raman J, Jeevanandam V, Gupta MP. Single-stranded DNA-binding proteins PURα and PURβ bind to a purine-rich negative regulatory element of the α-myosin heavy chain gene and control transcriptional and translational regulation of the gene expression: implications in the repression of α-myosin heavy chain during heart failure. J Biol Chem. 2003;278:44935-44948.
76. Ji J, Tsika GL, Rindt H, Schreiber KL, McCarthy JJ, Kelm RJ Jr., Tsika R. Purα and Purβ collaborate with Sp3 to negatively regulate β-myosin heavy chain gene expression during skeletal muscle inactivity. Mol Cell Biol. 2007;27:1531-1543.
77. Stewart AFR, Larkin SB, Farrance IKG, Mar JH, Hall DE, Ordahl CP. Muscle-enriched TEF-1 isoforms bind M-CAT elements from muscle-specific promoters and differentially activate transcription. J Biol Chem. 1994;269:3147-3150.
78. Zuzarte PC, Farrance IKG, Simpson PC, Wildeman AG. Tumor cell splice variants of the transcription factor TEF-1 induced by SV40 T-antigen transformation. Biochim Biophys Acta. 2000;1517:82-90.
79. Jiang S-W, Trujillo MA, Sakagashira M, Wilke RA, Eberhardt NL. Novel human TEF-1 isoforms exhibit altered DNA binding and functional properties. Biochemistry. 2000;39:3505-3513.
80. Yagi R, Kohn MJ, Karavanova I, Kaneko KJ, Vullhorst D, DePamphilis ML, Buonanno A. Transcription factor TEAD4 specifies the trophectoderm lineage at the beginning of mammalian development. Development. 2007;134:3827-3836.
81. Butler AJ, Ordahl CP. Poly(ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription. Mol Cell Biol. 1999;19:296-306.
82. Gupta MP, Gupta M, Zak R. An E-box/M-CAT hybrid motif and cognate binding protein(s) regulate the basal muscle-specific and cAMP-inducible expression of the rat cardiac α-myosin heavy chain gene. J Biol Chem. 1994;269:29677-29687.
83. Berberich C, Dürr I, Koenen M, Witzemann V. Two adjacent E box elements and a M-CAT box are involved in the muscle-specific regulation of the rat acetylcholine receptor β subunit gene. Eur J Biochem. 1993; 216:395-404.
84. O'Connell TD, Rokosh DG, Simpson PC. Cloning and characterization of the mouse α1C/A-adrenergic receptor gene and analysis of an α1C promoter in cardiac myocytes: role of an MCAT element that binds transcriptional enhancer factor-1 (TEF-1). Mol Pharmacol. 2001;59: 1225-1234.
85. Pasquet S, Naye F, Faucheux C, Bronchain O, Chesneau A, Thiébaud P, Thézé N. Transcription enhancer factor-1-dependent expression of the α-tropomyosin gene in the three muscle cell types. J Biol Chem. 2006; 281:34406-34420.